The Ritz-Carlton, Millenia Singapore has announced a groundbreaking partnership with EPICUTIS®, a science-driven skincare brand developed by Signum Biosciences. This collaboration marks the debut of EPICUTIS® in Southeast Asia, with The Ritz-Carlton Spa Singapore becoming the brand’s flagship property in the region. The partnership aims to redefine luxury wellness by integrating advanced molecular science with indulgent spa rituals.
The introduction of EPICUTIS® at The Ritz-Carlton Spa positions it as the first luxury spa in Southeast Asia to offer this cutting-edge skincare line. The collaboration reflects a growing trend in the luxury hospitality sector towards integrative health and holistic wellness. The spa’s exclusive menu now includes facials and advanced treatments that promise not only refined comfort but also clinically-proven therapeutic efficacy.
“The Ritz-Carlton Spa’s latest offerings seamlessly blend indulgent spa rituals with advanced molecular science,” the press release stated. This move underscores the hotel’s commitment to providing a balanced and refined lifestyle rooted in holistic well-being.
As the flagship property for EPICUTIS® in Southeast Asia, The Ritz-Carlton Spa Singapore is set to lead the way in luxury wellness, offering guests an unparalleled experience that combines the best of science and relaxation. This partnership is expected to enhance the spa’s reputation as a leader in luxury and innovation.
